Delivery Order SPE2DB20D2104-SPE2DB22FS40C
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. The contract has a ceiling value of $4,049.28 and a completion date of June 26, 2025. It is a firm fixed-price contract, which indicates the price is predetermined and not subject to adjustment based on the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract has a ceiling value of $2,903.46 and a completion date of June 13, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM) and serves as a critical supplier of medical and pharmaceutical products to federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract has a ceiling value of $9,200.92 and a completion date of February 27, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,758.80, is for the delivery of FYCOMPA 6 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of May 22, 2023 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,506.91, is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a prescription medication. The contract is a firm fixed-price delivery order, with a period of performance through May 8, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $6,767.54, is for the delivery of FYCOMPA 0.5 MG/ML oral suspension in 340 mL bottles. This is a firm-fixed price delivery order contract with a completion date of November 27, 2023. The contract is not associated with a set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of FYCOMPA 0.5 mg/mL oral suspension in 340 mL bottles. The contract has a firm fixed price of $1,660.60 and an ultimate completion date of August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Fycompa 0.5 mg/ml oral suspension in 340 ml bottles. The $5,304.12 firm fixed-price contract was awarded on May 31, 2022 by the Defense Logistics Agency, a defense agency of the U.S. government. The contract has a completion date of June 1, 2022 and was not set aside for any particular business type. Amerisourcebergen is a major pharmaceutical distributor that maintains a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.52 delivery order contract is for the supply of FYCOMPA 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract is for the supply of FYCOMPA 4 MG TABLET 30S, a prescription pharmaceutical product. The contract has a ceiling value of $1,673.88 and runs through September 16, 2024. This contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS40CDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract has a ceiling value of $2,791.81 and a completion date of April 14, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 4/13/22 |